IMR Press / FBL / Volume 5 / Issue 4 / DOI: 10.2741/habr

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Open Access Article
Role of endoscopic ultrasound in the diagnosis and staging of pancreatic cancer
Show Less
1 Department of Gastroenterology, Rhode Island Hospital, Brown University School of Medicine, Providence, RI 02903, USA
Academic Editor:Howard Safran
Front. Biosci. (Landmark Ed) 2000, 5(4), 30–35; https://doi.org/10.2741/habr
Published: 1 April 2000
(This article belongs to the Special Issue Novel approaches in the management of pancreatic cancer)
Abstract

Endoscopic Ultrasound (EUS) is a relatively new modality. Its high resolution makes it possible to detect tumors of 5mm in diameter otherwise missed by other imaging modalities. It is more accurate than computerized tomography (CT) scan, Transabdominal Ultrasound (US) and Magnetic Resonance Imaging (MRI) in diagnosing pancreatic lesions, especially those less than 20mm in diameter. EUS can be used to obtain pancreatic and nodal tissue using ultrasound- guided fine needle aspiration increasing the diagnostic yield and helping determining further management. It can also determine vascular involvement by pancreatic cancer with a sensitivity of more than 90%. The current indications for EUS in the diagnosis and management of pancreatic cancer will be reviewed.

Keywords
Endoscopic Ultrasound
Pancreatic Cancer
Staging
Review
Share
Back to top